Pathfinder Cell Financials
| PFND Stock | USD 0.0001 0.00 0.00% |
Pathfinder |
Please note, the presentation of Pathfinder Cell's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pathfinder Cell's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pathfinder Cell's management manipulating its earnings.
Pathfinder Cell Stock Summary
Pathfinder Cell competes with Xenon Pharmaceuticals, Ascletis Pharma, Cyclacel Pharmaceuticals, Molecular Partners, and PepGen. Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. PATHFINDER CELL operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 1 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 12 Bow Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.pathfindercelltherapy.com |
| Phone | 617 245 0289 |
| Currency | USD - US Dollar |
Pathfinder Cell Key Financial Ratios
There are many critical financial ratios that Pathfinder Cell's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Pathfinder Cell Therapy reports annually and quarterly.| Return On Asset | -8.89 | |||
| Beta | 0.14 |
Pathfinder Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pathfinder Cell's current stock value. Our valuation model uses many indicators to compare Pathfinder Cell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pathfinder Cell competition to find correlations between indicators driving Pathfinder Cell's intrinsic value. More Info.Pathfinder Cell Therapy is rated below average in return on asset category among its peers. It also is rated below average in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pathfinder Cell's earnings, one of the primary drivers of an investment's value.Pathfinder Cell Therapy Systematic Risk
Pathfinder Cell's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pathfinder Cell volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Pathfinder Cell Therapy correlated with the market. If Beta is less than 0 Pathfinder Cell generally moves in the opposite direction as compared to the market. If Pathfinder Cell Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pathfinder Cell Therapy is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pathfinder Cell is generally in the same direction as the market. If Beta > 1 Pathfinder Cell moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Pathfinder Pink Sheet analysis
When running Pathfinder Cell's price analysis, check to measure Pathfinder Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pathfinder Cell is operating at the current time. Most of Pathfinder Cell's value examination focuses on studying past and present price action to predict the probability of Pathfinder Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pathfinder Cell's price. Additionally, you may evaluate how the addition of Pathfinder Cell to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |